Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.

Post-Surgical Ocular Inflammation Clinical Trial

Official title:
A Randomized Controlled Clinical Trial aSsessing the Efficacy of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert When Placed Within the Upper Eye Lid Canaliculus in Comparison to the Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With Posterior Chamber Intraocular Lens Implant (CE/PCIOL).

Status Recruiting

Clinical Trial Summary

Assessing DEXTENZA efficacy when placed within the upper eyelid canaliculus as opposed to the lower eyelid canaliculus.

Clinical Trial Description

Randomized controlled clinical trial assessing the efficacy of DEXTENZA, sustained release dexamethasone 0.4 mg insert when placed within the upper eye lid canaliculus in comparison to the lower lid canaliculus following bilateral cataract extraction surgery with posterior chamber intraocular lens implant (CE/PCIOL). ;

Study Design

Related Conditions & MeSH terms

Cataract
Inflammation
Post-Surgical Ocular Inflammation
Post-Surgical Ocular Pain

Clinical Trial Details

NCT number	NCT04592081
Study type	Interventional
Source	Assil Eye Institute
Contact	Kellie Burch
Phone	310-651-2392
Email	kburch@assileye.com
Status	Recruiting
Phase	Phase 4
Start date	August 1, 2020
Completion date	March 11, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02736175` - OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery	Phase 3
Completed	`NCT04324359` - Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects	Phase 2
Completed	`NCT02089113` - OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery	Phase 3